LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial.
Meessen JMTA, Bär C, di Dona FM, Staszewsky LI, Di Giulio P, Di Tano G, Costa A, Leonardy J, Novelli D, Nicolis EB, Masson S, Pinet F, Thum T, Latini R.
Meessen JMTA, et al. Among authors: di dona fm, di tano g, di giulio p.
Clin Chem. 2021 Nov 26;67(12):1721-1731. doi: 10.1093/clinchem/hvab197.
Clin Chem. 2021.
PMID: 34751777
Clinical Trial.